FLORENCE, MA
4 risk indicators measuring financial stability and operational resilience
Sign in with your work email to view Tuckman-Chang indicators
Sign In — Free (10 views/day)INTERNATIONAL SOCIETY OF GLOMERULAR DISEASE, founded in 2022, is a small nonprofit in the Diseases & Disorders sector that reported $655K in total revenue in fiscal year 2024. Revenue grew 14% year-over-year, indicating healthy expansion. Expenses of $579K left a modest 12% surplus.
THE INTERNATIONAL SOCIETY OF GLOMERULAR DISEASE IS A MEDICAL SOCIETY FOUNDED IN 2022 TO PROVIDE A PHYSICIAN AND RESEARCHER CENTRIC PROFESSIONAL HOME FOR GLOMERULAR DISEASE EXPERTS. ISGD WAS INITIALLY ENVISIONED BY NEPHCURE AND ITS NETWORK OF GLOMERULAR HEALTH LEADERS. IT IS NOW AN INDEPENDENT NON PROFIT 501(C)(6) ORGANIZATION.
PROGRAM SERVICES INCLUDE ALL ACTIVITIES AROUND CREDENTIALING, PEER SUPPORT, EDUCATION, CLINICAL TRIALS, AND TRANSLATIONAL RESEARCH. CREDENTIALING: CONNECTING USERS WITH GLOMERULAR EXPERTSPEER...
PROGRAM SERVICES INCLUDE ALL ACTIVITIES AROUND CREDENTIALING, PEER SUPPORT, EDUCATION, CLINICAL TRIALS, AND TRANSLATIONAL RESEARCH. CREDENTIALING: CONNECTING USERS WITH GLOMERULAR EXPERTSPEER SUPPORT: COMMUNITY BUILDING AND CLINIC AVAILABILITYEDUCATION: PROMOTION OF BEST PRACTICESCLINICAL TRIALS: EXPANDED ACCESS TO TRIALSTRANSLATIONAL RESEARCH: RESEARCH SUPPORT
Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency
Sign in to view Trantor Score and financial metrics
Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)
Sign In — Free (10 views/day)| 2024 | 2023 | Change | |
|---|---|---|---|
| Revenue | $654,920 | $576,023 | +0.1% |
| Expenses | $579,400 | $403,435 | +0.4% |
| Net Income | $75,520 | $172,588 | -0.6% |
Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics
Financial Distress Indicator
Liquidity & Cash Position
Sign in to view all financial metrics
Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics
Sign In| Name | Title | Hours/Week | Role | Reportable Comp | Other Comp | Total |
|---|---|---|---|---|---|---|
| LAUREL J DAMASHEK | EXECUTIVE DIRECTOR | 40.00 |
Officer
|
$140,268 | $5,611 | $145,879 |
| IRVING SMOKLER | BOARD CHAIR | 1.00 |
Officer
|
$0 | $0 | $0 |
| JOSHUA TARNOFF | SECRETARY | 1.00 |
Officer
|
$0 | $0 | $0 |
| SHARON ADLER | TREASURER | 1.00 |
Officer
|
$0 | $0 | $0 |
| TOBIAS B HUBER | SOCIETY PRESIDENT | 1.00 |
Officer
|
$0 | $0 | $0 |
| Year | Revenue | Expenses | Assets | Net Income |
|---|---|---|---|---|
| 2024 | $654,920 | $579,400 | $546,458 | $75,520 |
| 2023 | $576,023 | $403,435 | $190,660 | $172,588 |
Compare INTERNATIONAL SOCIETY OF GLOMERULAR DISEASE with other nonprofits in Massachusetts and across the country.